rs7241307
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001378183.1(PIEZO2):c.1201-19C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0634 in 1,495,352 control chromosomes in the GnomAD database, including 3,319 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.056 ( 293 hom., cov: 33)
Exomes 𝑓: 0.064 ( 3026 hom. )
Consequence
PIEZO2
NM_001378183.1 intron
NM_001378183.1 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.31
Publications
5 publications found
Genes affected
PIEZO2 (HGNC:26270): (piezo type mechanosensitive ion channel component 2) The protein encoded by this gene contains more than thirty transmembrane domains and likely functions as part of mechanically-activated (MA) cation channels. These channels serve to connect mechanical forces to biological signals. The encoded protein quickly adapts MA currents in somatosensory neurons. Defects in this gene are a cause of type 5 distal arthrogryposis. Several alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known. [provided by RefSeq, Feb 2014]
PIEZO2 Gene-Disease associations (from GenCC):
- Gordon syndromeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
- arthrogryposis, distal, with impaired proprioception and touchInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Illumina, Ambry Genetics
- arthrogryposis- oculomotor limitation-electroretinal anomalies syndromeInheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
- connective tissue disorderInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- Marden-Walker syndromeInheritance: AR, AD Classification: MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 18-10801447-G-C is Benign according to our data. Variant chr18-10801447-G-C is described in ClinVar as Benign. ClinVar VariationId is 261496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0646 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PIEZO2 | NM_001378183.1 | c.1201-19C>G | intron_variant | Intron 9 of 55 | ENST00000674853.1 | NP_001365112.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PIEZO2 | ENST00000674853.1 | c.1201-19C>G | intron_variant | Intron 9 of 55 | NM_001378183.1 | ENSP00000501957.1 |
Frequencies
GnomAD3 genomes AF: 0.0562 AC: 8556AN: 152160Hom.: 293 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
8556
AN:
152160
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0519 AC: 7578AN: 146006 AF XY: 0.0521 show subpopulations
GnomAD2 exomes
AF:
AC:
7578
AN:
146006
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0643 AC: 86305AN: 1343074Hom.: 3026 Cov.: 30 AF XY: 0.0637 AC XY: 42335AN XY: 664686 show subpopulations
GnomAD4 exome
AF:
AC:
86305
AN:
1343074
Hom.:
Cov.:
30
AF XY:
AC XY:
42335
AN XY:
664686
show subpopulations
African (AFR)
AF:
AC:
1375
AN:
30588
American (AMR)
AF:
AC:
1547
AN:
35622
Ashkenazi Jewish (ASJ)
AF:
AC:
1266
AN:
24958
East Asian (EAS)
AF:
AC:
40
AN:
35516
South Asian (SAS)
AF:
AC:
3385
AN:
78322
European-Finnish (FIN)
AF:
AC:
2978
AN:
35210
Middle Eastern (MID)
AF:
AC:
161
AN:
5634
European-Non Finnish (NFE)
AF:
AC:
72230
AN:
1040482
Other (OTH)
AF:
AC:
3323
AN:
56742
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.451
Heterozygous variant carriers
0
3625
7251
10876
14502
18127
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2712
5424
8136
10848
13560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0562 AC: 8560AN: 152278Hom.: 293 Cov.: 33 AF XY: 0.0566 AC XY: 4213AN XY: 74458 show subpopulations
GnomAD4 genome
AF:
AC:
8560
AN:
152278
Hom.:
Cov.:
33
AF XY:
AC XY:
4213
AN XY:
74458
show subpopulations
African (AFR)
AF:
AC:
1918
AN:
41558
American (AMR)
AF:
AC:
663
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
182
AN:
3468
East Asian (EAS)
AF:
AC:
23
AN:
5186
South Asian (SAS)
AF:
AC:
195
AN:
4826
European-Finnish (FIN)
AF:
AC:
932
AN:
10610
Middle Eastern (MID)
AF:
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4506
AN:
68016
Other (OTH)
AF:
AC:
126
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
423
846
1269
1692
2115
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
96
192
288
384
480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
81
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.